Ad is loading...
ABT
Price
$116.81
Change
-$0.00 (-0.00%)
Updated
Dec 2 closing price
49 days until earnings call
SYK
Price
$390.97
Change
+$1.34 (+0.34%)
Updated
Dec 3 closing price
62 days until earnings call
Ad is loading...

ABT vs SYK

Header iconABT vs SYK Comparison
Open Charts ABT vs SYKBanner chart's image
Abbott Laboratories
Price$116.81
Change-$0.00 (-0.00%)
Volume$5.34M
CapitalizationN/A
Stryker
Price$390.97
Change+$1.34 (+0.34%)
Volume$923.88K
CapitalizationN/A
ABT vs SYK Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABT vs. SYK commentary
Dec 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongBuy and SYK is a Buy.

COMPARISON
Comparison
Dec 04, 2024
Stock price -- (ABT: $116.81 vs. SYK: $390.97)
Brand notoriety: ABT: Notable vs. SYK: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 104% vs. SYK: 77%
Market capitalization -- ABT: $194.5B vs. SYK: $134.94B
ABT [@Medical Specialties] is valued at $194.5B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 2 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • ABT’s FA Score: 2 green, 3 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than ABT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).

  • ABT’s TA Score: 5 bullish, 2 bearish.
  • SYK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABT is a better buy in the short-term than SYK.

Price Growth

ABT (@Medical Specialties) experienced а -1.12% price change this week, while SYK (@Medical Specialties) price change was +0.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +8.81%. For the same industry, the average monthly price growth was +10.79%, and the average quarterly price growth was +2.32%.

Reported Earning Dates

ABT is expected to report earnings on Jan 22, 2025.

SYK is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Medical Specialties (+8.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than SYK($135B). SYK has higher P/E ratio than ABT: SYK (42.99) vs ABT (34.38). SYK YTD gains are higher at: 31.457 vs. ABT (7.759). ABT has higher annual earnings (EBITDA): 10.5B vs. SYK (4.93B). ABT has more cash in the bank: 7.28B vs. SYK (3.05B). SYK has less debt than ABT: SYK (13B) vs ABT (15.6B). ABT has higher revenues than SYK: ABT (40.1B) vs SYK (20.5B).
ABTSYKABT / SYK
Capitalization194B135B144%
EBITDA10.5B4.93B213%
Gain YTD7.75931.45725%
P/E Ratio34.3842.9980%
Revenue40.1B20.5B196%
Total Cash7.28B3.05B238%
Total Debt15.6B13B120%
FUNDAMENTALS RATINGS
ABT vs SYK: Fundamental Ratings
ABT
SYK
OUTLOOK RATING
1..100
6417
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
3812
SMR RATING
1..100
5649
PRICE GROWTH RATING
1..100
5127
P/E GROWTH RATING
1..100
5760
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (11) in the Medical Specialties industry is in the same range as SYK (20). This means that ABT’s stock grew similarly to SYK’s over the last 12 months.

SYK's Profit vs Risk Rating (12) in the Medical Specialties industry is in the same range as ABT (38). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.

SYK's SMR Rating (49) in the Medical Specialties industry is in the same range as ABT (56). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.

SYK's Price Growth Rating (27) in the Medical Specialties industry is in the same range as ABT (51). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.

ABT's P/E Growth Rating (57) in the Medical Specialties industry is in the same range as SYK (60). This means that ABT’s stock grew similarly to SYK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTSYK
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
51%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
52%
Momentum
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 9 days ago
58%
Bullish Trend 8 days ago
58%
Declines
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 14 days ago
51%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
47%
Aroon
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
53%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDXX432.111.34
+0.31%
IDEXX Laboratories
WNC19.650.02
+0.10%
Wabash National Corp
WOW5.14-0.02
-0.39%
WideOpenWest
BNT60.94-0.74
-1.20%
Brookfield Wealth Solutions Ltd
TPST0.87-0.08
-8.14%
Tempest Therapeutics

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-0.45%
MDT - ABT
46%
Loosely correlated
-0.96%
SYK - ABT
41%
Loosely correlated
+0.34%
TMO - ABT
41%
Loosely correlated
+0.84%
TFX - ABT
39%
Loosely correlated
-3.18%
HOLX - ABT
38%
Loosely correlated
-1.94%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
+0.34%
BSX - SYK
67%
Closely correlated
+0.04%
ISRG - SYK
54%
Loosely correlated
-0.21%
ZBH - SYK
47%
Loosely correlated
+0.22%
SNN - SYK
43%
Loosely correlated
-0.23%
EW - SYK
42%
Loosely correlated
-0.47%
More